Skip to Content
Merck

36-009

Anti-β-Synuclein (SNCB) Antibody

UPSTATE®, mouse monoclonal, Syn207

Sign In to View Organizational & Contract Pricing.

Select a Size

About This Item

UNSPSC Code:
12352203
eCl@ss:
32160702
NACRES:
NA.41
Clone:
Syn207, monoclonal
Species reactivity:
rat, mouse, human
Application:
IHC, WB
Citations:
15

Key Documents

View All Documentation
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Product Name

Anti-β-Synuclein Antibody, clone Syn207, ascites fluid, clone Syn207, Upstate®

biological source

mouse

antibody form

ascites fluid

antibody product type

primary antibodies

clone

Syn207, monoclonal

species reactivity

rat, mouse, human

manufacturer/tradename

Upstate®

technique(s)

immunohistochemistry: suitable, western blot: suitable

NCBI accession no.

NM_001001502.1, NM_003085.3

UniProt accession no.

Q16143

shipped in

dry ice

target post-translational modification

unmodified

Quality Level

100

Gene Information

human ... SNCB(6620)

Looking for similar products? Visit Product Comparison Guide

General description

~17kDa

Immunogen

full length recombinant human β-Synuclein

Application

Anti-β-Synuclein Antibody, clone Syn207 is an antibody against β-Synuclein for use in WB, IH.
Research Category
Neuroscience
Research Sub Category
Neurodegenerative Diseases

Biochem/physiol Actions

recombinant β-Synuclein

Physical form

Ascites
ascites with 0.05% sodium azide

Preparation Note

2 years at -20°C

Analysis Note

routinely evaluated by immunoblot lot detected β-Synuclein recombinant protein

Legal Information

UPSTATE is a registered trademark of Merck KGaA, Darmstadt, Germany

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Not finding the right product?  

Try our Product Selector Tool.

Storage Class

10 - Combustible liquids

wgk

WGK 1

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

P H Tu et al.
Annals of neurology, 44(3), 415-422 (1998-09-28)
Recently, alpha-synuclein was shown to be a structural component of the filaments in Lewy bodies (LBs) of Parkinson's disease (PD), dementia with LBs (DLB) as well as the LB variant of Alzheimer's disease, and this suggests that alpha-synuclein could play
B I Giasson et al.
Journal of neuroscience research, 59(4), 528-533 (2000-02-19)
To facilitate studies of the normal biology of alpha-synuclein, a member of a family of neuronal proteins of unknown function, and to elucidate the role of alpha-synuclein pathologies in neurodegenerative diseases, we generated and characterized a panel of anti-synuclein antibodies.
O Akil et al.
Journal of the Association for Research in Otolaryngology : JARO, 9(4), 452-463 (2008-07-31)
Synucleins are widely expressed synaptic proteins within the central nervous system that have been implicated in such neurodegenerative disorders as Parkinson's disease. In this study, an initial characterization of all three synucleins, alpha-, beta-, and gamma-synuclein, within the cochlea was
Suna Lahut et al.
Disease models & mechanisms, 10(5), 619-631 (2017-01-22)
Parkinson's disease (PD) is a frequent neurodegenerative process in old age. Accumulation and aggregation of the lipid-binding SNARE complex component α-synuclein (SNCA) underlies this vulnerability and defines stages of disease progression. Determinants of SNCA levels and mechanisms of SNCA neurotoxicity
Oxidative modifications of alpha-synuclein.
Ischiropoulos, Harry
Annals of the New York Academy of Sciences, 991, 93-100 (2003)
View All Related Papers

Global Trade Item Number

SKUGTIN
36-00904053252371936

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service